Thrivent Financial for Lutherans
AGN

Thrivent Financial for Lutherans’s Allergan Inc AGN Stock Holding History

Thrivent Financial for Lutherans’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-7,050
Closed -$1.5M – 1911
2014
Q4 		$1.5M Buy
7,050
+50
+0.7% +$9.94K 0.01% 755
2014
Q3 		$1.25M Hold
7,000
– – 0.01% 811
2014
Q2 		$1.19M Hold
7,000
– – 0.01% 835
2014
Q1 		$869K Buy
7,000
+100
+1% +$12.2K 0.01% 757
2013
Q4 		$766K Hold
6,900
– – ﹤0.01% 825
2013
Q3 		$624K Sell
6,900
-3,400
-33% -$305K ﹤0.01% 832
2013
Q2 		$868 Buy
+10,300
New +$1.07M 0.01% 734

Other funds holding AGN

California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
CA
Commerzbank Aktiengesellschaft Frankfurt, Germany $4.78B AUM 25.31% 1-Year Est. Return
ECM
Everence Capital Management Goshen, Indiana $1.64B AUM 26.46% 1-Year Est. Return
HFS
HL Financial Services Louisville, Kentucky $6.5B AUM 9.56% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Thrivent Financial for Lutherans's AGN Position: Q1 2015 in Review

Thrivent Financial for Lutherans sold out of Allergan Inc (AGN) in Q1 2015, closing a stake of 7,050 shares — an estimated $1.5M sold.

Thrivent Financial for Lutherans first reported a position in AGN in Q2 2013 and held it in 7 quarters. The position peaked at $1.5M in Q4 2014. 5 funds tracked by Wall St. Rank hold AGN as of Q1 2015.

  • Thrivent Financial for Lutherans reported no remaining Allergan Inc position as of Q1 2015 after selling out during the quarter.
  • Thrivent Financial for Lutherans sold 7,050 Allergan Inc shares in Q1 2015, an estimated $1.5M.
  • Thrivent Financial for Lutherans first reported a position in Allergan Inc in Q2 2013 and held it in 7 quarters.
  • Thrivent Financial for Lutherans's Allergan Inc position peaked at $1.5M in Q4 2014.
  • 5 funds tracked by Wall St. Rank held Allergan Inc as of Q1 2015.

Based on Thrivent Financial for Lutherans's 13F filing for Q1 2015, filed 15 May 2015.